Acorah Software Products - Accounts Production19.4.300falsetruefalsetrueNo description of principal activity25 March 202531 March 202631 March 202616342062Mrs Amy Lutheriso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure163420622025-03-24163420622026-03-31163420622025-03-252026-03-3116342062frs-core:CurrentFinancialInstruments2026-03-3116342062frs-bus:PrivateLimitedCompanyLtd2025-03-252026-03-3116342062frs-bus:FilletedAccounts2025-03-252026-03-3116342062frs-bus:Micro-entities2025-03-252026-03-3116342062frs-bus:AuditExempt-NoAccountantsReport2025-03-252026-03-3116342062frs-bus:Director12025-03-252026-03-31
Registered number: 16342062
Molecular Medical Services Ltd
Financial Statements
For The Year Ended 31 March 2026
My Accountant Friend
50 St Marys Road
Hemel Hempstead
Herts
HP2 5HL
Molecular Medical Services Ltd
Balance Sheet
As At 31 March 2026
Balance Sheet
Registered number: 16342062
2026
£
Current assets
76,186
Creditors: Amounts Falling Due Within One Year
(34,744)
NET CURRENT ASSETS
41,442
TOTAL ASSETS LESS CURRENT LIABILITIES
41,442
NET ASSETS
41,442
CAPITAL AND RESERVES
41,442
Notes
1.General Information
Molecular Medical Services Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16342062. The registered office is Lamorak House Arthurs Court, Sleepers Hill, Winchester, SO22 4NB.
2.Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.